Aardvark Therapeutics Inc

AARDNASDAQ · USD
5.38USD0.00 (-2.72%)
2310

Aardvark Therapeutics Inc (AARD) Implied Volatility Current

AARD implied volatility is 176%. IV Rank is —%, placing current premiums in the middle of their 52-week range.

Read more

Tracking AARD implied volatility helps you identify when options premiums on Aardvark Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Aardvark Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when AARD IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Aardvark Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For AARD, tracking metrics like AARD IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on AARD signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is the ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen that is in Phase III clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in Phase II clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from treatment of craniopharyngioma, including surgery or radiation.

It also developing ARD-201, which is in Phase I clinical trial for the treatment of obesity. The company was incorporated in 2017 and is based in San Diego, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where AARD implied volatility sits today versus where it has been. Our scanner ranks Aardvark Therapeutics Inc implied volatility against its historical range, surfaces extremes in AARD IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Aardvark Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
IV Rank
Implied Volatility (30d)176.31%

IV Rank

Historical Volatility (30d)110.07%

IV - HV+66.24%

As of September 18, 2026

Trade options with IV on your side

Track AARD IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial